|Day's Range||48.64 - 48.90|
|52 Week Range||31.47 - 49.53|
|PE Ratio (TTM)||-69.64|
|Earnings Date||Aug 7, 2017 - Aug 11, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||49.25|
On April 14, 2017, Abbott Laboratories (ABT) agreed to acquire point-of-care diagnostics player Alere (ALR) for an equity value of ~$5.3 billion.
WALTHAM, Mass., May 22, 2017 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced certain preliminary unaudited financial information for the fourth quarter ...
Surging implied volatility makes Alere (ALR) Stock lucrative to the option traders.